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doi:10.1016/j.jtcvs.2005.11.032s of August 5, 2005 there were 96,189 patients awaiting organ transplantation.
During 2004 only 27,036 transplants were performed, highlighting a growing
disparity between patients listed and organs available. The United Network for
rgan Sharing (UNOS) is charged with coordinating the sharing of organs to ensure
airness and optimal utilization, and they also monitor the outcomes of all listed and
ransplanted patients. This wealth of information, which is accessible to the medical
ommunity and patients, was analyzed by Dr. Mokadam and colleagues,1 and as a
esult, they have raised concerns about the welfare of patients listed as status 2 (not
notrope-dependent, usually at home; patients listed as status 1A are hospitalized on
evices or inotropes and patients listed as status 1B are on inotropes) during their
rolonged wait for a heart transplant. Of the 1265 patients analyzed, 30% deteriorated
nd 10% died. Before responding to these concerns, I would like to take a closer look
t how patients are doing while waiting for a heart transplant.
Since 1994, there has been a dramatic and unanticipated decline in the annual
umber of heart transplants performed in the United States. As reported by UNOS,
uring the past decade, heart transplants have been declining at a rate of 1% to 2%
er year from a peak of 2528 in 1995 to 2016 in 2004. Arguing against donor
hortages as the cause, the number of patients listed annually also declined from a
eak of 4079 in 1998 to 2802 in 2002. There has also been a shortening of the
ggregate waiting time despite news to the contrary. In Mokadam’s review the
edian wait time for patients listed as status 2 was 406 days.
This information is accurate but somewhat misleading. UNOS presents times as
time to transplant” and “waiting time before transplant.” Time to transplant includes
ctive and inactive time; waiting time is only active time. A patient may be inactivated
or many reasons—too sick (early after left ventricular assist device [LVAD] insertion),
oo well, psychosocial, and personal—and physicians are reluctant to remove the
atients from the list because they will lose their accumulated time on the list. The
umber of patients classified as “temporarily inactive” at the end of the calendar year
ncreased over the decade from 33% to 48% of patients listed. Figure 1 shows the time
o transplant with patients listed as status 2 waiting substantially longer; Figure 2 shows
substantial reduction in waiting times when only active time is considered. Currently
NOS does not tabulate the reasons for inactive listing or which status level is more
ommonly inactive. It makes little sense to me to discuss waiting times unless this is
hen you are actively looking for a donor organ for the patient.
Great strides have been made in reducing the mortality of the patients on the waiting
ist (Figure 3). For all statuses listed, death rates have declined, with patients listed as
tatus 2 having the lowest risk of dying while awaiting transplant. Two commonly
ffered justifications for transplanting patients listed as status 2 are that they do better
fter transplantation compared with patients listed as status 1 and they do poorly if they
eteriorate and need urgent mechanical support or transplantation. The available data
efutes this. The unadjusted 1-year survival is higher for patients listed as status 2 when
ompared with patients listed as status 1A (88% vs 81%, respectively). However, when
djusted for other covariates, status at listing does not impact survival after transplan-
ation.2 Using the same UNOS data as Mokadam did, Jimenez and colleagues found that
eterioration to status 1A or 1B from status 2 did not impact survival after
ransplantation.3
Although the information presented in their brief communication is true, it does not
ccurately reflect the trends I have outlined from the UNOS database when analyzed on
he basis of actively listed patients and using death rates rather than simple proportions.
wo concerns were raised by the authors: it is ethically unjustifiable to conduct a
rospective randomized trial of medical therapy versus transplantation in status 2
The Journal of Thoracic and Cardiovascular Surgery ● Volume 131, Number 4 775
p
l
r
1
a
1
s
n
c
t
w
m
C
a
C
M
M
s
t
N
t
i
h
i
a
t
t
p
a
n
w
a
t
F
t
a
f
R
1
2
3
4
Editorials Smedira
7
ED
ITO
RIA
Latients and it is premature to divert organs from local patients
isted as status 2. UNOS allocates hearts locally (in the city or
egion of the donor hospital) first, with patients listed as status
A, 1B, and 2 considered, and then the hearts would be
llocated to patients listed as status 1A or 1B within 500, then
000, nautical miles of the donor hospital. In Ohio we have a
haring arrangement that supersedes this, and all hearts do-
ated in Ohio are shared among transplant centers and allo-
ated by status—1A before 1B before 2. UNOS has proposed
hat the first offer would be to patients listed as status 1A or 1B
ithin 500 miles of the donor hospital. To comprehend how
any centers this would impact, as an example with the
leveland Clinic at the center of a circle with a 500-mile radius
nd a flying time of approximately 90 minutes, a donor in
leveland could be shared with centers as far away as Augusta,
aine; Savannah, Georgia; Memphis, Tennessee; St Louis,
issouri; and St Paul, Minnesota. From the data I have pre-
Figure 1. Time to transplantation for all statuses.
400
300
200
100
93 94 95 96 97
Time to transplant
Median wait time
Year of Waiting List Registration
98 99 0100 02
0
D
a
y
sFigure 2. Time to and waiting time until transplantation.
76 The Journal of Thoracic and Cardiovascular Surgery ● Apriented and our experience with an in-state sharing agreement,
his makes a great deal of sense. Transplant News reported on
ovember 30, 2005 that this allocation scheme was adopted by
he UNOS Board of Directors and they predict a 7% reduction
n pretransplant deaths in both adults and pediatrics.4
Should we consider randomizing patients listed as status 2? I
ave not seen a protocol to comment on. The reason this question
s being asked by transplant physicians is because at 1 and 2 years
fter being listed as status 2, 50% and 20% of patients, respec-
ively, are alive without transplantation or deterioration. Rather
han a trial, an effort should be made to understand why some
atients remain clinically stable after listing.
The transplant community should take great pride in the
dvances in cardiovascular medicine that have reduced the
umber of patients needing to be actively listed, reduced the
aiting time for those listed, improved the safety of patients
waiting transplantation, and developed an allocation scheme
hat accurately identifies patients at greatest risk of dying.
urther refinement of medical therapies and modifications of
he allocation system should be implemented if they reduce the
ggregate mortality for all patients requiring a heart transplant.
The author thanks Drs Randall C. Starling and James B. Young
or their assistance in the preparation of this editorial.
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